Gennova’s mRNA vaccine candidate for COVID-19 gets DCGI nod for human clinical trials
It is an indigenous mRNA vaccine candidate supported with seed grant under the Ind-CEPI mission of Department of Biotechnology of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
HGCO19
DBT seed funds Gennova Biopharmaceuticals’ novel mRNA-based COVID-19 vaccine candidate
The clinical trials for the vaccine are likely to start before the year ends